Hypertension: A new therapeutic strategy for PAH

Nature Reviews Nephrology 11, 445 (2015). doi:10.1038/nrneph.2015.107 Author: Ellen F. Carney Selective targeting of BMPR-II signalling using BMP9 could be a promising strategy for the treatment of pulmonary arterial hypertension (PAH), according to a new study. “This potential therapy targets the most common genetic cause of the disease—a pathway that is known to also be dysfunctional
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research